Shockwave Medical's (SWAV) Reducer Receives Positive Results

Shockwave Medical, Inc. (SWAV) recently announced that the researchers provided interim long-term follow-up results of up to three years, along with six-month data from the entire population of the REDUCER-I investigation. These results support the favorable, "real-world" results of Shockwave Reducer, a cutting-edge treatment for refractory angina.Results of the study were presented at the 73rd Annual Scientific Sessions of the American College of Cardiology in Atlanta, GA.Price PerformanceIn the past six m ...